Molecular Medicine: Promises,Promises?

Watson J.D. , Crick F.H.C. A structure for deoxyribose nucleic acid. Nature 1953; 171: 737–8

Wilkins M.H. , Stokes A.R. , Wilson H.R. Molecular structure of deoxypentose nucleic acids. Nature 1953; 171: 738–40

Watson J.D. The Double Helix. New York: Norton, 1980

Judson H.F. The Eighth Day of Creation: Makers of the Revolution in Biology. New York: Cold Spring Harbor Press, 1996

Anon . Steps on the road to modern day biotechnology [http://fig.cox.miami.edu/-cmallery/150/hisbiotech/hisbiotech.htm]. Accessed February 2005

Human Genome Project [www.ornl.gov/sci/techresources/Human_Genome/home.shtml]. Accessed February 2005

Weatherall D.J. The New Genetics and Clinical Practice. London: Nuffield Hospitals Provincial Trust, 1982

Le Fanu J. The Rise and Fall of Modern Medicine. London: Little, Brown, 1999

Willard H.F. , Davies K.E. Genetics of disease—complex genetics, complex diseases. Curr Opin Genet Dev 1998; 8: 271–3

Kimmelman J. Recent developments in gene transfer: risks and ethics. BMJ 2005; 330: 79–82

Aiuti A. , Ficara F. , Cattaneo F. , Bordignon C. , Roncarlo M.G. Gene therapy for adenosine deaminase deficiency. Curr Opin Allergy Clin Immunol 2003; 3: 461–6

Pfeifer A. , Verma I.M. Gene therapy: promises and problems. Annu Rev Genomics Hum Genet 2001; 2: 177–211

Marshall E. Clinical trials: gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244–5

Kohn D.B. , Sadelan M. , Glorioso J.C. Occurrence of leukaemia following gene therapy of X-linked SCID 2. Nature Rev Cancer 2003; 3: 477–8

Wadhwa P.D. , Zielske S.P. , Roth J.C. . Cancer gene therapy: scientific basis. Annu Rev Med 2002; 53: 437–52

Ryther R.C.C. , Flynt A.S. , Phillips J.A. , Patton J.G. siRNA therapeutics: big potential from small RNAs. Gene Therapy 2005; 12: 5–11

Thiel G. , Lietz M. , Hohl M. How mammalian transcriptional repressors work. Eur J Biochem 2004; 271: 2855–62

PCR Fact Sheet [www.genome.gov/10000207]. Accessed February 2005

Yirrell D.L. , Pickering H. , Palmarini L. . Molecular epidemiological analysis of HIV in sexual networks in Uganda. AIDS 1998; 12: 285–90

Mazars E. , Lesjean B. , Bamuls A.L. . High-resolution microsatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis: molecular epidemiology. Proc Natl Acad Sci USA 2001; 98: 1901–6

Gillespie S.H. , ed. Methods in Molecular Medicine. Antibiotic Resistance, Methods and Protocols. Totowa NJ: Humana Press, 2000

OMIM (Online Mendelian Inheritance in Man) [www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM]. Accessed February 2005

Khoury M.J. , McCabe L.L. , McCabe E.R.B. Population screening in the age of genomic medicine. N Engl J Med 2003; 348: 50–8

Scourfield J. , Soldan J. , Gray J. , Houlihan G. , Harper P.S. Huntington's disease: psychiatric practice in molecular genetic prediction and diagnosis. Br J Psychiatry 2001; 170: 146–9

Lerman C. , Shields A.E. Genetic testing for cancer susceptibility: the promise and the pitfalls. Nat Rev Cancer 2004; 4: 235–41

Lobb E. , Meiser B. Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer. Lancet 2004; 363: 1841–2

Scheuer L. , Kauff N. , Robson M. . Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002; 20: 1260–8

Vogelstein B. , Kinzler K.W. Cancer genes and the pathways they control. Nat Med 2004; 10: 789–9

Hanash S. Integrated global profiling of cancer. Nat Rev Cancer 2004; 4: 638–43

Burnett A.K. Presenting white cell count and kinetics of molecular remission predict prognosis in APMI treated with all-trans retinoic acid: results of randomised MRC trial. Blood 1999; 93: 4131–43

Johnston M.I. , Hoth D.E. Present status and future prospects for HIV therapies. Science 1993; 260: 1286–93

Bell R. , Verma S. , Untech M. , Cameron D. , Smith I. Maximising clinical benefit with trastuzamab. Semin Oncol 2004; 31(suppl 10): 35–44

Maini S.R. Infliximab treatment of rheumatoid arthritis. Rheum Dis Clin N Am 2004; 30: 329–47

Fischer O.M. , Streit S. , Hart S. , Ullrich A. Beyond Herceptin and Gleevec. Curr Opin Chem Biol 2003; 7: 490–5

Anon . The future of cancer treatment: up close and personal. Economist 2004; 373: 75–8

Clark D.W. , Layton D. , Shakir S.A. Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology. Drug Saf 2004; 27: 427–56

Multiple authors. The Human Genome Comes of Age. FT Biotechnology, Special Report. Financial Times, 10 November 2004